|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics. CA Cancer J Clin. 59:225–249. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006.PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu
L and He J: The incidences and mortalities of major cancers in
China, 2009. Chin J Cancer. 32:106–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wagner AD, Grothe W, Haerting J, Kleber G,
Grothey A and Fleig WE: Chemotherapy in advanced gastric cancer: a
systematic review and meta-analysis based on aggregate data. J Clin
Oncol. 24:2903–2909. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thompson EW, Newgreen DF and Tarin D:
Carcinoma invasion and metastasis: a role for
epithelial-mesenchymal transition? Cancer Res. 65:5991–5995. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y, Wen M, Kwon Y, et al: CUL4A
induces epithelial-mesenchymal transition and promotes cancer
metastasis by regulating ZEB1 expression. Cancer Res. 74:520–531.
2014. View Article : Google Scholar
|
|
7
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: new insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Graham TR, Zhau HE, Odero-Marah VA, et al:
Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives
epithelial-to-mesenchymal transition in human prostate cancer
cells. Cancer Res. 68:2479–2488. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Walsh LA and Damjanovski S: IGF-1
increases invasive potential of MCF 7 breast cancer cells and
induces activation of latent TGF-β1 resulting in epithelial to
mesenchymal transition. Cell Commun Signal. 9:102011. View Article : Google Scholar
|
|
10
|
Lorenzatti G, Huang W, Pal A, Cabanillas
AM and Kleer CG: CCN6 (WISP3) decreases ZEB1-mediated EMT and
invasion by attenuation of IGF-1 receptor signaling in breast
cancer. J Cell Sci. 124:1752–1758. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Adachi Y, Li R, Yamamoto H, et al:
Insulin-like growth factor-I receptor blockade reduces the
invasiveness of gastrointestinal cancers via blocking production of
matrilysin. Carcinogenesis. 30:1305–1313. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ge J, Chen Z, Wu S, et al: Expression
levels of insulin-like growth factor-1 and multidrug
resistance-associated protein-1 indicate poor prognosis in patients
with gastric cancer. Digestion. 80:148–158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Franciosi CM, Piacentini MG, Conti M, et
al: IGF-1 and IGF-1BP3 in gastric adenocarcinoma. Preliminary
study. Hepatogastroenterology. 50:297–300. 2003.PubMed/NCBI
|
|
14
|
Robertson JF, Ferrero JM, Bourgeois H, et
al: Ganitumab with either exemestane or fulvestrant for
postmenopausal women with advanced, hormone-receptor-positive
breast cancer: a randomised, controlled, double-blind, phase 2
trial. Lancet Oncol. 14:228–235. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Trajkovic-Arsic M, Kalideris E and Siveke
JT: The role of insulin and IGF system in pancreatic cancer. J Mol
Endocrinol. 50:R67–R74. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim HJ, Litzenburger BC, Cui X, et al:
Constitutively active type I insulin-like growth factor receptor
causes transformation and xenograft growth of immortalized mammary
epithelial cells and is accompanied by an epithelial-to-mesenchymal
transition mediated by NF-kappaB and snail. Mol Cell Biol.
27:3165–3175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sivakumar R, Koga H, Selvendiran K,
Maeyama M, Ueno T and Sata M: Autocrine loop for IGF-I receptor
signaling in SLUG-mediated epithelial-mesenchymal transition. Int J
Oncol. 34:329–338. 2009.PubMed/NCBI
|
|
18
|
Irie HY, Pearline RV, Grueneberg D, et al:
Distinct roles of Akt1 and Akt2 in regulating cell migration and
epithelial-mesenchymal transition. J Cell Biol. 171:1023–1034.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Papkoff J and Aikawa M: WNT-1 and HGF
regulate GSK3 beta activity and beta-catenin signaling in mammary
epithelial cells. Biochem Biophys Res Commun. 247:851–858. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sineva GS and Pospelov VA: Inhibition of
GSK3beta enhances both adhesive and signalling activities of
beta-catenin in mouse embryonic stem cells. Biol Cell. 102:549–560.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ho MY, Tang SJ, Chuang MJ, Cha TL, Li JY,
Sun GH and Sun KH: TNF-α induces epithelial-mesenchymal transition
of renal cell carcinoma cells via a GSK3β-dependent mechanism. Mol
Cancer Res. 10:1109–1119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng H, Li W and Wang Y: Glycogen
synthase kinase-3 beta regulates Snail and β-catenin expression
during Fas-induced epithelial-mesenchymal transition in
gastrointestinal cancer. Eur J Cancer. 49:2734–2746. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lowry OH, Rosebrough NJ, Farr AL and
Randall RJ: Protein measurement with the Folin phenol reagent. J
Biol Chem. 193:265–275. 1951.PubMed/NCBI
|
|
24
|
Miyoshi A, Kitajima Y, Sumi K, Sato K,
Hagiwara A, Koga Y and Miyazaki K: Snail and SIP1 increase cancer
invasion by upregulating MMP family in hepatocellular carcinoma
cells. Br J Cancer. 90:1265–1273. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Remacle JE, Kraft H, Lerchner W, et al:
New mode of DNA binding of multi-zinc finger transcription factors:
deltaEF1 family members bind with two hands to two target sites.
EMBO J. 18:5073–5084. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Elloul S, Elstrand MB, Nesland JM, et al:
Snail, Slug, and Smad-interacting protein 1 as novel parameters of
disease aggressiveness in metastatic ovarian and breast carcinoma.
Cancer. 103:1631–1643. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mikaelian I, Malek M, Gadet R, et al:
Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a
TGF-β-independent mechanism. Cancer Res. 73:6621–6631. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gregory PA, Bracken CP, Smith E, et al: An
autocrine TGF- beta/ZEB/miR-200 signaling network regulates
establishment and maintenance of epithelial-mesenchymal transition.
Mol Biol Cell. 22:1686–1698. 2011. View Article : Google Scholar : PubMed/NCBI
|
